Markus Sieger
CIK 1337143 · last filed 2026-01-30
Markus Sieger is a corporate insider who has filed 47 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider was granted $37.5K of RFL on Jan 30, 2026. Across all open-market trades the lifetime net is +$329.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $562.5K across reported positions. 3 SEC filings were submitted jointly with Rafael Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$562.5K
4
47
$329.8K
Filer Profile
CH-8032
ZURICH, V8 000000000
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RFL | Director | 219,710 | $2.56 | $562.5K | $0 | 1 | 2026-01-30 |
| Rafael Holdings, Inc. (RFL.WS) Delisted | Director | 190,182 | $0.01 | $2.7K | $0 | 1 | 2025-05-29 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Director | 440,260 | $0.03 | $14.1K | $214.4K | 23 | 2025-03-03 |
| CENTRAL EUROPEAN DISTRIBUTION CORP (CEDC) Delisted | Director | 17,500 | — | — | $115.4K | 8 | 2011-08-22 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-30 | RFL | Grant (A) | +29,528 | $37.5K | EDGAR |
| 2025-05-29 | Rafael Holdings, Inc. (RFL.WS) Delisted | Exer (X) | +35,000 | $44.8K | EDGAR |
| 2025-03-03 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +58,138 | $0 | EDGAR |
| 2024-11-18 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +35,022 | $0 | EDGAR |
| 2024-08-20 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +18,354 | $0 | EDGAR |
| 2024-06-05 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +18,067 | $0 | EDGAR |
| 2024-02-15 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +14,004 | $0 | EDGAR |
| 2023-11-30 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +16,512 | $0 | EDGAR |
| 2023-10-23 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Mixed | +59,881 | $42.5K | EDGAR |
| 2023-08-22 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +16,269 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.